28 July 2017 | Statement

Unitaid marks World Hepatitis Day

Unitaid joins the global health community today to mark World Hepatitis Day, an occasion for raising public awareness of the epidemic of curable liver viruses that cause 1.34 million deaths each year.

Unitaid is helping to defeat the epidemic by investing US$ 58 million in three grant projects (2015-2019) aimed at hepatitis C (HCV). The projects seek to develop new and simpler diagnostics, establish innovative models for screening and treatment in HIV/HCV co-infected populations, and devise cost-reduction strategies.


Unitaid’s investments in HCV:

 Read more:

View All News

Featured News

18 October 2017

Unitaid-led working group will study how to fight antimicrobial resistance through access to innovative treatments and diagnostics

Read More

13 October 2017

Unitaid joins Call to Action on antimicrobial resistance in Berlin

Read More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.